Suppr超能文献

利用病毒样颗粒优化用于生物物理和结构研究的重组 G 蛋白偶联受体。

Optimization of Recombinant GPCR Proteins for Biophysical and Structural Studies Using Virus-like Particles.

机构信息

Biology Department, Vertex Pharmaceuticals, San Diego, CA, USA.

Neuroscience TRC, Bristol Myers Squibb, San Diego, CA, USA.

出版信息

Methods Mol Biol. 2022;2507:327-336. doi: 10.1007/978-1-0716-2368-8_17.

Abstract

Overexpression of biologically functional GPCRs and homogeneous purified protein solutions are required to enable structural studies and protein-based biophysical assay development. Iterative and time-consuming optimization cycles of protein engineering, expression, and purification are often needed to achieve the desired protein quantity and quality. Here, we describe the reconstitution of GPCRs in virus-like particles (VLPs) and their use in biophysical assays to characterize protein yield, stability, and small molecule ligand binding. This approach prevents the need for time-consuming detergent solubilization and protein purification during recombinant GPCR protein optimization.

摘要

需要表达具有生物功能的 G 蛋白偶联受体 (GPCR) 和均一的纯化蛋白溶液,以支持结构研究和基于蛋白质的生物物理检测方法的开发。通常需要对蛋白质工程、表达和纯化进行反复和耗时的优化循环,以获得所需的蛋白质数量和质量。在这里,我们描述了将 GPCR 重构成病毒样颗粒 (VLPs),并将其用于生物物理检测方法中,以表征蛋白质产量、稳定性和小分子配体结合。这种方法避免了在优化重组 GPCR 蛋白时需要耗时的去污剂溶解和蛋白纯化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验